Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18 influenza seasons

Mark Reacher*, Ben Warne, Neville Q. Verlander, Ashley Popay, Lucy Reeve, Nicholas K. Jones, Kyriaki Ranellou, Nyaradzai Sithole, Rory Carpenter, Angharad Everden, Elizabeth Jarman, Ali Khalid, Kyle Lam, Chloe Myers, Shuhui Ren, Kathryn J. Rolfe, Tommy Sutton, Silvana Christou, Callum Wright, Saher ChoudhryMaria Zambon, Clare Sander, Hongyi Zhang, Hamid Jalal

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Fingerprint

Dive into the research topics of 'Oseltamivir is protective for in-patient mortality in PCR confirmed influenza B and influenza A(H3N2) infections in an historic cohort of 1,048 patients hospitalised during the 2016-17 and 2017-18 influenza seasons'. Together they form a unique fingerprint.

Keyphrases

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology